1 / 41

EXERCISE

EXERCISE. A patient presents to your office with complaints like: I have no energy I get tired just walking to the mailbox I can only steep sitting up I’ve gained weight, but I have no appetite 5.I have to go to the bathroom several times at night. CONGESTIVE HEART FAILURE. BY

dalia
Download Presentation

EXERCISE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. EXERCISE A patient presents to your office with complaints like: I have no energy I get tired just walking to the mailbox I can only steep sitting up I’ve gained weight, but I have no appetite 5.I have to go to the bathroom several times at night

  2. CONGESTIVE HEART FAILURE BY LEBURA EWONUBARI GRACE ROLL NO: 666

  3. OUTLINE • DEFINITION • ETIOLOGY/CAUSES • EPIDEMIOLOGY • PATHOGENESIS • PATHOPHYSIOLOGY • SIGNS AND SYMPTOMS • RISK FACTORS • CLASSIFICATION:STAGES/TYPES • DIAGNOSIS • PROGNOSIS • COMPLICATIONS • PREVENTION • TREATMENT • SUMMARY • REFERENCES

  4. DEFINITION • The term Congestive Heart failure • or cardiac failure means simply • failure of the heart to • pump enough blood to satisfy • the needs of the body

  5. ETIOLOGY/CAUSES • Myocardial infarction • Viral myocarditis • Coronary artery disease • Long term hypertension • Infiltrations of the muscle such as amyloidosis

  6. EPIDEMIOLOGY • leading cause of hospitalization • In people older than 65 • 6.6million people in the US • 23 milion people worldwide. • Men have a higher incidence • women survive longer

  7. PATHOGENESIS • (1) reduced cardiac output and • (2) volume overload due to damming • of blood in the veins, • resulting in increased venous pressure.

  8. PATHOPHYSIOLOGY • Reduced force of contraction, due • to overloading of the ventricle • A reduced stroke volume, due to • failure of systole, diastole or both • Increased heart rate, • stimulated by increased sympathetic activity • in order to maintain cardiac output.

  9. SIGNS AND SYMPTOMS • Shortness of breath • Fatigue and weakness • Swelling (edema) in your legs • Increased need to urinate at night • Swelling of abdomen (ascites) • Sudden weight gain • Elevated blood pressure

  10. RISK FACTORS Age • Hypertension • Diabetes • Obesity • Coronary artery disease • High cholesterol and triglycerides • Prior heart attack

  11. STAGES • The American College of Cardiology/ • American Heart Association stages patients according to the progression of • their heart failure: • Stage A: High risk for developing heart failure • Stage B: Asymptomatic heart failure • Stage C: Symptomatic heart failure • Stage D: Refractory end-stage heart failure

  12. The New York Heart Association • classifies patients based on their • physical limitations. Classifications are as follows: • Class I: No limitations of physical activity • Class II: Slight limitation • Class III: Marked limitation • Class IV: Severe limitation

  13. TYPESLEFT SIDED FAILURE • Due to Decreased ventricular contraction (systolic dysfunction) • Causes of systolic dysfunction: • Ischemia due to coronary artery atherosclerosis • Post-myocardial infarction, myocardial fibrosis, myocarditis, dilated cardiomyopathy • Noncompliantventricle (diastolicdysfunction) • Restricted filling of the left ventricle • in diastole due to essential hypertension

  14. Clinical features: • Pulmonary congestion leads to pulmonary edema. • i. Results in dyspnea, paroxysmal nocturnal dyspnea, orthopnea, and crackles • Decreased flow to kidneys leads • to activation of renin-angiotensin system Fluid retention exacerbates CHF

  15. RIGHT SIDED FAILURE • Most commonly due to • left-sided heart failure • left to right shunt and • chronic lung disease (corpulmonale). • Due to: Decreased contraction • b. Noncompliant right ventricle • c. Increased afterload

  16. Clinical features are due to congestion. • 1. Jugular venous distension • 2. Painful hepatosplenomegaly with characteristic 'nutmeg' liver , may lead to cardiac cirrhosis • 3. Dependent pitting edema (due to increased hydrostatic pressure)

  17. SYSTOLIC FAILURE • stroke volume is reduced because • ventricular contraction is weak. • the ejection fraction falls from • 65% to as low as 20%. • The initial response to failure • is activation of the genes that cause cardiac myocytes to hypertrophy, • and thicken of the ventricular wall (cardiac remodeling).

  18. DIASTOLIC FAILURE • the ejection fraction is initially • maintained but the elasticity of the myocardium is reduced so filling during diastole is reduced. • This leads to inadequate stroke volume • and the same cardiac remodeling • and Na' and water retention • that occur in systolic failure.

  19. HIGH OUTPUT FAILURE • cardiac output is increased compared • with values for the normal resting state, • due to:. Increase in stroke volume . (Eg hyperthyroidism) • Decrease in blood viscosity • Decrease total peripheral resistance (TPR) • Increase venous return to the heart. (Egsevere anemia)

  20. LOW OUTPUT FAILURE • After acute heart attacks and • often after prolonged periods of • slow progressive cardiac deterioration, the heart becomes incapable of pumping • even the minimal amount of blood flow required to keep the body alive. • Consequently, all the body tissues • begin to suffer and even to deteriorate, • often leading to death within a few hours to a few days.

  21. PHYSICAL EXAMINATION • In mild or moderately severe HF, • the patient appears to be • in no distress at rest except • for feeling uncomfortable • In more severe HF, • the patient must sit upright, • may have labored breathing

  22. Examination of the jugular veins • provides an estimation of right atrial pressure. • Pulmonary crackles (rales or crepitations) result from the transudation of • fluid from the intravascular space • into the alveoli. • In patients with pulmonary edema, • ralesmay be heard widely over both lung fields

  23. In some patients, a third • heart sound (S3) is audible • and palpable at the apex. • Patients with enlarged or hypertrophied • right ventricles may have a sustained • and prolonged left parasternal impulse extending throughout systole.

  24. Hepatomegaly is an important sign • Ascites, a late sign, • occurs as a consequence of increased pressure in the hepatic veins and • the veins draining the peritoneum. • Jaundice, also a late finding in HF, • results from impairment of hepatic • function secondary to hepatic congestion

  25. DIAGNOSIS • Routine Laboratory Testing • Patients with new-onset HF • and those with chronic HF • and acute decompensation should have • a complete blood count, a panel of electrolytes, blood urea nitrogen, serum creatinine, hepatic enzymes, and a urinalysis.

  26. Electrocardiogram (ECG) • The major importance of the ECG • is to assess cardiac rhythm and • determine the presence of LV hypertrophy • or a prior MI (presence or absence of Q waves

  27. Chest X-Ray • A chest x-ray provides useful information about cardiac size and shape, • as well as the state • of the pulmonary vasculature, and • may identify noncardiac causes of • the patient's symptoms.

  28. Assessment of LV Function • Noninvasive cardiac imaging is essential • for the diagnosis, evaluation, and management of HF.

  29. Biomarkers • Both B-type natriuretic peptide (BNP) • and N-terminal pro-BNP, which are • released from the failing heart, • are relatively sensitive markers for the presence of HF with depressed EF

  30. they also are elevated in HF • patients with a preserved EF, • albeit to a lesser degree. • Other biomarkers, such as troponin T • and I, C-reactive protein, TNF receptors, • and uric acid, may be elevated in HF.

  31. Exercise Testing • Treadmill or bicycle exercise testing • is not routinely advocated for • patients with HF, but either • is useful for assessing the need • for cardiac transplantation in patients • with advanced HF .

  32. PROGNOSIS • In general, the mortality following hospitalization for patients with heart • failure is 10.4% at 30 days, • 22% at 1 year, and 42.3% at 5 years, • despite marked improvement in medical • and device therapy. • Each rehospitalization increases mortality by about 20-22%.

  33. COMPLICATIONS • Kidney damage or failure • Heart valve problems • Liver damage • Stroke:Because blood flow through • the heart is slower in heart failure • than in a normal heart, blood clots can develop.

  34. PREVENTION • control or eliminate many of • the risk factors for heart disease —: • high blood pressure and coronary artery disease, for example. • Not smoking • Controlling certain conditions, such as • high blood pressure, high cholesterol and diabetes • Staying physically active

  35. TREATMENT • ACE INHIBITORS • ANGIOTENSIN RECEPTOR BLOCKERS(ARBs) • BETA BLOCKERS • DIURETICS • For valve problem: valve repair or replacement is done. • Coronary artery bypass graft(CABG)

  36. Angioplasty (open up closed artery) • Severe cases may require surgical • implants such as pacemakers, ventricular assist device (VAD).

  37. SUMMARY • CHF occurs when the heart • is unable to pump blood at • a rate that meets the metabolic • requirements of the peripheral tissue; • inadequate cardiac output is usually accompanied by increased congestion of • the relevant venous circulation.

  38. Left-sided heart failure is most • commonly due to IHD, • systemic hypertension, mitral or aortic valve disease, and primary diseases of the myocardium; symptoms are primarily related to pulmonary congestion and edema.

  39. Right-sided heart failure is • most commonly due to left-sided • heart failure or to primary pulmonary diseases; • it is associated with peripheral • edema and visceral congestion.

  40. REFERENCES • Arthur S, Philip A.(2002). The Heart: Congestive Heart Failure. Board Review Series pathology, 2nd Edition. 144 – 145. • Edward G.(2010): Heart Disorders: Rapid Review Pathology, 3rd Edition. 158 – 164. • Guyton and Hall (2006). Cardiac Failure. Textbook of Medical Physiology, Eleventh Edition.258-268. • Henry S, John B.(2010). Cardiac Pathology: Congestive Heart failure. Kaplan Medical USMLE Step1. 144-145 • Husain A.(2011). Cardiac Pathology: congestive heart failure. Fundamentals of Pathology, Medical Course and step 1 Review, First Edition. 76 • Kumar et al(2007). The Heart:heart failure. Robbins Basic Pathology, 8th Edition. • Longo et al(2012). Disorders of Cardiovascular system: disorders of the heart. Harrison’s Principles of Internal Medicine, 18th Edition. • Stephen J.M and Gary D.H.(2010). Cardiovascular disorders:Heart disease. Pathophysiology of Disease, 6th Edition. • William F. G. (2005). Cardiovascular Homeostasis in Health and Disease: Heart Failure. Review of Medical Physiology, Twenty -Second Edition. 643- 644.

  41. Check your heart today

More Related